Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
It has passed phase 1 and 2 clinical trials and is currently in phase 3 trials, with an expected launch in 2026 or 2027 if approved
Tracking peptide results helps identify whether storage compromises affected potency
Provider review is recommended to determine whether GHK-Cu is appropriate for your individual health profile before starting any protocol
Inhibiting inflammation
US$ 23.72
US$ 22.77
US$ 23.47
US$ 24.59
US$ 28.12
US$ 23.79
